Clinical Trial Update: Abatacept s.c. for aGVHD Prevention in Haplo-HCT [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates for Abatacept subcutaneous formulation in preventing acute graft-versus-host disease after haploidentical hematopoietic cell transplantat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Haploidentical Hematopoietic Cell Transplantation

Drugs mentioned

• Abatacept (abatacept)

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Abatacept, Acute-graft-versus-host Disease | Phase 1, Phase 2 | Status: UNKNOWN